Stocks and Investing
Stocks and Investing
Mon, December 11, 2023
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
[ Mon, Dec 11th 2023
] - WOPRAI
Jason McCarthy Initiated (ATXI) at Strong Buy and Held Target at $56 on, Dec 11th, 2023
Jason McCarthy of Maxim Group, Initiated "Avenue Therapeutics, Inc." (ATXI) at Strong Buy and Held Target at $56 on, Dec 11th, 2023.
Jason, nor any peers, have made any analyst calls on ATXI in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources